Early Chest Tube Removal for Collapsed Lung
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are taking immunosuppressive medications like chemotherapy or steroids, you may not be eligible to participate.
What data supports the effectiveness of early chest tube removal as a treatment for a collapsed lung?
Research suggests that early chest tube removal after certain surgeries, like video-assisted thoracoscopic surgery (a type of lung surgery), can reduce patient discomfort without increasing risks. This implies that early removal might be safe and beneficial in similar situations, such as treating a collapsed lung.12345
Is early chest tube removal generally safe for humans?
Research suggests that early chest tube removal can be safe and may reduce pain and speed up recovery after surgeries like lung and heart operations. However, there is a risk of fluid buildup in the chest that might need further treatment, so it should be done carefully and under medical supervision.13678
How does early chest tube removal differ from standard chest tube removal for a collapsed lung?
Early chest tube removal is unique because it involves taking out the chest tube sooner than usual, which can reduce pain and speed up recovery, but it may also increase the risk of fluid buildup that requires further treatment. This approach contrasts with the standard practice of waiting longer to remove the tube to ensure all air or fluid is drained from the chest.148910
What is the purpose of this trial?
Video-assisted thoracoscopic surgery (VATS) with blebectomy/wedge resection plus pleurodesis is the standard of care for recurrent primary spontaneous pneumothorax (PSP) or, in certain instances, after the first episode. The chest tube from surgery is typically kept to suction until post-operative day (POD) 2 to allow for scarring of the lung to the chest to prevent recurrence. However, the scarring process takes place over a period of weeks and is there no data to support POD#2 as the best time to remove the chest tube. Also, shorter chest tube duration can lower length of stay, patient discomfort, and hospital cost.The goal of this randomized study is to determine if early removal (POD#1) of chest tube after video-assisted thoracoscopic surgery (VATS) with blebectomy/wedge resection plus chemical pleurodesis for primary spontaneous pneumothorax (PSP):* has no worse 2-year recurrence rate compared to standard removal (POD#2)* will lower length of stay compared to standard removal* will result in less complications or re-interventions compared to standard removalParticipants will be asked to join prior to surgery. Following standard-of-care surgery, participants will be screened for randomization. If still eligible, participants will be randomized for early chest tube removal or standard removal. Early Removal will happen within 24 hours after surgery, with Standard Removal happening day 2 after surgery.Participants will follow-up with the study team for 2 years on the following schedule:* In clinic with a chest x-ray 2 weeks after surgery* By phone 3 months after surgery* In clinic with a chest x-ray 1 year after surgery* In clinic with a chest x-ray 2 years after surgery
Eligibility Criteria
This trial is for individuals who have had a lung collapse, known as primary spontaneous pneumothorax, and are undergoing surgery. Participants should be fit for the study before their operation and willing to follow up for 2 years with visits and phone calls.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo VATS with blebectomy/wedge resection and pleurodesis, followed by randomization to early or standard chest tube removal
Follow-up
Participants are monitored for safety and effectiveness after treatment with scheduled follow-ups
Treatment Details
Interventions
- Early Chest Tube Removal
- Standard Chest Tube Removal
Find a Clinic Near You
Who Is Running the Clinical Trial?
Swedish Medical Center
Lead Sponsor